[Time to revise guidelines concerning anticoagulants in atrial fibrillation].
Terént
Andreas
A
Strokesektionen, Medicincentrum, Akademiska sjukhuset, Uppsala. andreas.terent@medicin.uas.lul.se
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D000075202:Contraindications; D003657:Decision Making; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D011322:Primary Prevention; D014859:Warfarin / Q000009:adverse effects
D000925:Anticoagulants; D014859:Warfarin